☒~~QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

☐ ~~TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ þNo ☐o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ þNo ☐o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act: ☐o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ oNo ☒x

As of ~~November 18, 2021,~~May 23, 2022, there were ~~726,167,847~~772,012,967 shares of the registrant’s common stock outstanding.

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~September 30,~~MARCH 31, 2022, and 2021 ~~AND 2020~~

The accompanying ~~notes~~footnotes are an integral part of these unaudited condensed consolidated financial statements.

~~STATEMENT~~CONDENSED Consolidated STATEMENTS of CHANGES IN STOCKHOLDERS’ DEFICIT

The accompanying ~~notes~~footnotes are an integral part of these unaudited condensed consolidated financial statements.

The Company was incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation (“Global”). The merger was treated as a recapitalization of Global, and Creative changed its name to Global Digital Solutions, Inc. (“the Company”, “we”), Global provided structured cabling design, installation and maintenance for leading information technology companies, federal, state, and local government, major businesses, educational institutions, and telecommunication companies. On May 1, 2012, the Company made the decision to wind down their operations in the telecommunications area and to refocus efforts in the area of cyber arms technology and complementary security and technology solutions. From August 2012 through November 2013, the Company was actively involved in managing Airtronic USA, Inc., and effective as of June 16, 2014, they acquired North American Custom Specialty Vehicles (“NACSV”). In July 2014, the Company announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead their efforts overseas. The Company had limited operations from the NACSV subsidiary from December 31, 2015, until May 13, 2016. During the interim, the Company was pursuing acquisition opportunities and responding to the litigation with the Securities and Exchange Commission. Subsequent to May 13, 2016, the Company has been seeking acquisitions and additional financing.

In March of 2019, the Company acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA is developing an updated version of the system known as Pilot Assisted Landing Systems (PALS). The precision and robustness of PALS is expected to generate a host of new applications mainly through “landing trajectory” optimization which provides additional safety margin against weather related hazardous conditions, like wind shear, wake turbulence, icing, as well as low ceilings and fog.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has sustained losses and experienced negative cash flows from operations since inception, and for the ~~nine-months~~three months ended ~~September 30, 2021,~~March 31, 2022, while it had net ~~income~~loss of approximately ~~$2,042,351,~~$930,000, which was mostly the result of ~~the change in fair value~~amortization expense of ~~the derivative liability,~~approximately $482,000, the Company used net cash of ~~approximately $1,900,000~~$119,773 to fund operating activities at ~~September 30, 2021,~~March 31, 2022, had an accumulated deficit of approximately ~~$49,518,532,~~$50,280,000, and a working capital deficit of approximately $~~13,343,720~~$11,603,000. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of the financial statements. The Company has funded its activities to date almost exclusively from equity and debt financings.

The Company needs to raise additional funds immediately and continue to raise funds until they begin to generate sufficient cash from operations and may not be able to obtain the necessary financing on acceptable terms, or at all.

The Company will continue to require substantial funds to continue development of its core business. Management’s plans in order to meet the operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which management expects will lead to the generation of additional revenue or acquisition opportunities.

While Management believes that the Company will be successful in obtaining the necessary financing to fund operations, there are no assurances that such additional funding will be achieved or that they will succeed in future operations.

Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

The accompanying unaudited financial information as of and for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022, and 2021 ~~and 2020~~ has been prepared in accordance with accounting principles generally accepted in the U.S. for interim financial information and with the instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments, unless otherwise indicated) considered necessary for a fair presentation of our financial position at such date and the operating results and cash flows for such periods. Operating results for the three ~~and nine~~ months ended ~~September 30, 2021~~March 31, 2022, are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission, or the SEC. These unaudited financial statements and related notes should be read in conjunction with our Annual Report on Form 10-K that includes the audited financial statements for the year ended December 31, ~~2020~~2021, as filed with the SEC on April ~~19, 2021.~~20, 2022.

The condensed consolidated balance sheet at December 31, 2020, has been derived from the audited financial statements at that date but does not include all the information and footnotes required by generally accepted accounting principles in the U.S. for complete financial statements.

The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and Aviation Services f/k/a HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period.

Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020.~~2021. The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits. As of ~~September 30, 2021,~~March 31, 2022, the bank balance is not over the federally insured limit. As of March 31, 2022, and December 31, ~~2020, the Company’s cash balance did not exceed FDIC coverage. As of September 30,~~ 2021, ~~and December 31, 2020, the Company did not have any~~we had no cash equivalents.

The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging”. Subtopic ASC 815-15, Embedded Derivatives generally requires companies to bifurcate conversion options embedded in the convertible notes from their host instruments and to account for them as free-standing derivative financial instruments. Derivative liabilities are recognized in the consolidated balance sheet at fair value as Derivative Liabilities and based on the criteria specified in FASB ASC 815-40, Derivatives and Hedging – Contracts in Entity’s own Equity. The estimated fair value of the derivative liabilities is calculated using various assumptions and such estimates are revalued at each balance sheet date, with changes recorded to other income or expense as Change in fair value of derivative liability in the condensed consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the instrument origination date and reviewed at the end of each event date (i.e. conversions, payments, etc.) and the measurement period end date for financial reporting, as applicable.

Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.

The following table summarizes the securities that were ~~included in~~excluded from the diluted per share ~~calculation:~~calculation because the effect of including these potential shares was antidilutive:

In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award.

The Company’s accounting policy for equity instruments issued to advisors, consultants and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the advisor, consultant or vendor is reached or (ii) the date at which the advisor, consultant or vendor’s performance is complete. In the case of equity instruments issued to advisors and consultants, the fair value of the equity instrument is recognized over the term of the advisor or consulting agreement. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable.

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.”

Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. accounting standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first.

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The Company is currently evaluating the impact that ASU 2020-06 may have on its consolidated financial statements and related disclosures.

Management is evaluating ~~other~~the new accounting pronouncements but doesn’t expect them to have material impact on our financial position or results of operations.

The Company evaluates events that have occurred after the balance sheet date of ~~September 30, 2021,~~March 31, 2022, through the date which the financial statements were issued. Based upon the review, other than described in Note 12 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

As of ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020,~~2021, accrued expenses consist of the following amounts:

We had no Level 1 or Level 2 assets and liabilities at ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020.~~2021. The Derivative liabilities are Level 3 fair value measurements.

The following is a summary of activity of Level 3 liabilities during the periods ended ~~September 30, 2021~~March 31, 2022, and December 31, ~~2020:~~2021:

-11-

September 30,
2021

December 31,
2020

Warrant liability:
Balance at beginning of period $ — $ —
Additions 2,398,000 —
Change in fair value (894,000 ) —
Balance at end of period $ 1,504,000 $ —

At ~~September 30, 2021,~~March 31, 2022, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using ~~a bi-nomial option model with~~ the following weighted-average inputs: the price of the Company’s common stock of ~~$0.03;~~$0.05; a risk-free interest rate ofranging from ~~0.05%~~0.06% to 0.09%, the expected volatility of the Company’s common stock ofranging from ~~143.35%~~150.19% to 171.53%; ~~and~~ the estimated remaining term, a dividend rate of 0%. and the various estimated reset exercise prices weighted by probability. At December 31, ~~2020,~~2021, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest ~~rate -~~rate- ~~.08%~~1.3%; term – 2.5 months ~~months~~ volatility – ~~103.71%~~246.62% dividend rate – 0%

During August 2017, Dragon Acquisitions, a related entity owned by William Delgado, and an individual lender entered into a promissory note agreement for $20,000 as well as $2,000 in interest to accrue through maturity on August 31, 2018 for a total of $22,000 due on August 31, 2018. The lender has extended the maturity date to December 31, 2021. Dragon Acquisitions assumed payment of a payable of the Company and the Company took on the note. The Company defaulted on the note at maturity in August 2018. The $20,000 note remained outstanding at ~~September 30,~~December 31, 2021 and ~~December 31, 2020~~ through the date of this report.

On December 22, 2017, the Company entered into a financing agreement with Parabellum, an accredited investor, for $1.2 million, which was then amended in 2020 and increased to $2,550,000. Under the terms of the agreement, the Company is to receive milestone payments based on the progress of the Company’s lawsuit (see Note 6) for damages against Grupo Rontan Metalurgica, S.A (the “Lawsuit”). Such milestone payments consist of (i) an initial purchase price payment of $300,000, which the Company received on December 22, 2017, (ii) $150,000 within 30 days of the Lawsuit surviving a motion to dismiss on the primary claims, (iii) $100,000 within 30 days of the close of all discovery in the Lawsuit and (iv) $650,000 within 30 days of the Lawsuit surviving a motion for summary judgment and challenges on the primary claims. As part of the agreement, the Company shall pay the investor an investment return of 100% of the litigation proceeds to recoup all money invested, plus 27.5% of the total litigation proceeds received by the Company. As ~~of September 30, 2021~~March 31,2022, and December 31, ~~2020,~~2021, and through the date of this report, the $2,550,000 note remains outstanding.

On December 23, 2017 (the “Effective Date”) the Company entered into a $485,000, 7% interest rate, demand promissory note with Vox Business Trust, LLC (“Vox”). The note was in settlement of the amounts accrued under a consulting agreement (see Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to Vox when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, Vox may not demand payment prior to the date of the Resolution Funding Date.

The Company shall make mandatory prepayment in the following amounts and at the following times –

Under the terms of the Vox note consulting agreement (see Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the ~~three and nine-month~~three-month period ended ~~September 30, 2021,~~March 31, 2022, consulting fees totaling ~~$30,000 and $90,000~~$65,000 were added to the note principal and are included in the note balance of ~~$896,500,~~$991,500, as of ~~September 30, 2021,~~March 31, 2022, and ~~$806,500~~$926,500 as of December 31, ~~2020.~~2021. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default. However, Vox has voluntarily refrained from making demand prior to the resolution funding date.

On December 26, 2017 (the “Effective Date”), the Company entered into a $485,000, 7% interest rate, demand promissory note with RLT Consulting, Inc. (“RLT”), a related party. The note was in settlement of the amounts accrued under a consulting agreement (see Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to RLT when resolution progress funding was met on December 22, 2017. As part of the agreement, RLT may not demand payment prior to the date of the resolution funding date. The Company also agreed to grant 5,000,000 shares within 90 days of the resolution progress funding date and 10,000,000 shares within 90 days of the resolution funding date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –

Under the terms of the RLT note consulting agreement (see Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the ~~three and nine-month~~three-month period ended ~~September 30, 2021,~~March 31, 2022, consulting fees totaling ~~$30,000 and $90,000, respectively,~~$72,000 were added to the note principal and are included in the note balance of ~~$889,500~~$991,500 as of ~~September 30, 2021~~March 31, 2022, and ~~$799,500~~$919,500 as of December 31, ~~2020.~~2021.

Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default. However, RLT has voluntarily refrained from making demand prior to the resolution funding date. RLT was granted a first priority security interest in the litigation proceeds and is pari passu to Parabellum and Vox. To that end, they share in the litigation in a priority position to proceed to repay the note.

During April 2018, the Company entered into a two-month $36,000 note payable with $31,000 in proceeds paid directly to a third-party vendor for expenses. The note did not bear interest and included a $5,000 original issue discount. During June 2018, the Company defaulted on the note. The lender has extended the maturity date to December 31, 2021. ~~The Company paid $25,000 in April 2021.~~ As of December 31,2021, and March 31, ~~2020 an September 30, 2021~~2022, and through the date of this report, ~~the note remained~~$11,000 remain outstanding.

During May 2018, the Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. The lender has extended the maturity date to December 31, 2021. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three (3) years. As of ~~September 30, 2021~~March 31, 2022, and December 31, ~~2020,~~2021, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding. The note is past the maturity date and has not been repaid through the date the financial statements were issued.

During June 2018, the Company entered in to a one-year $300,000 non-convertible note with an accredited investor with $150,000 original issue discount (“OID”) for net proceeds of $150,000. As part of the note agreement, the Company also agreed to issue the investor 5,000,000 warrants at an exercise price of $0.01, exercisable for a period of three (3) years. The Company defaulted on the note at maturity in June ~~2019.~~2019 and the note remained outstanding through the date of this report. The note contains a default interest rate of 10% plus a 5% penalty of the outstanding balance of the note. The note holder has voluntarily refrained from making demand for repayment under the default provisions of the note, which would require the Company to pay the holder 130% of the outstanding principal and interest accrued at the default rate. The remaining principal and accrued interest of the note was paid in full on March 10, 2021.

The June 2018 note bears a personal guarantee by William Delgado, the Chief Executive Officer of the Company. As further security for the note, Mr. Delgado has also pledged the 1,000,000 Convertible Preferred Shares of the Company that he owns, as well as 5,000,000 common shares of another public company in which Mr. Delgado is a director and Chief Financial Officer.

On May 12, 2020, the Company obtained a Paycheck Protection Program (“PPP”) loan in the amount of $103,125 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred until December 12, 2020, at which time the balance is payable in $5,805 monthly installments through May 12, 2022, if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company used the PPP loan proceeds for payroll, healthcare benefits, and utilities. The program provided that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act.

On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% promissory note in the aggregate principal of $251,625, with a maturity date of June 7, 2022. The note included a original issuance discount (“OID”) of $22,875, for a purchase price of $228,750. The interest was applied as a one time interest charge upon the issuance date, in the amount of $20,130, recognized in accrued interest. The month payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company ~~is required at have authorized and reserved four times~~has requested debt forgiveness from the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business.

In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $0.03, with a 3-year term. The warrants and the OID resulted in a debt discount of $105,875, which will be amortized using the effective interest method over the life of the note. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. The Company estimated the fair value of the warrant using the Black Scholes pricing model. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.03 at issuance date, a risk-free interest rate of 0.79% and expected volatility of the Company’s common stock of 143,5%, resulting in a fair value of $83,000.SBA. As of ~~September 30,~~March 31, 2022, and December 31, 2021, and through the date of this report the ~~principal balance of $197,274.00 is outstanding.~~SBA has not responded to the request and NNVA has waived the monthly payment

~~On March 25, 2021, the Company and GS Capital Partners LLC entered into a security purchase agreement for a Prime rate plus 8%~~ Convertible Note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request. On April 1, 2021, the Company received the first tranche of $1,000,000. Upon the receipt of the first tranche, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $917,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $184,000. On May 24, 2021, the Company received the second tranche from GS Capital Partners LLC, for $796,000’ less an OID of $99,500. On July 21, 2021 the Company received the balance of the second tranche for $346,857 less an OID of $48,357. As of September 30, 2021, and through the date of this report, the principal balance of the two tranches totaling $2,285,714 is outstanding.

On January 15, 2021, the Company and Power Up Lending Group entered into a securities purchase agreement for a 10% convertible note in the aggregate principal of $88,500 due on January 15, 2022. The conversion price is equal to the variable conversion price which is defined as 61% of the market price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and will be accounted for as a derivative liability on the date the note becomes convertible. On July 13, 2021, the Company paid off the note, plus accrued interest and redemption fees, for a total payment of $130,078.

On March 1, 2021, the Company received the first tranche of $1,000,000. In connection with the first tranche, the Company issued 10,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of September 30, 2021, and through the date of this report, the principal balance totaling $1,142,875 is outstanding. The note is due on February 25, 2022.

On April 7, 2020, the Company and Auctus Fund, LLC entered into a securities purchase agreement for a 12% convertible promissory in the aggregate principal of $197,000 due on February 7, 2021. The noteholder agreed to an extension of the maturity date to May 31, 2021 for a settlement amount of $344,548, including interest. The note is convertible into shares of the Company’s common stock. The conversion price shall equal the lessor of (i) Current Market Price, or (ii) Variable Market price as defined as Market Price less a 50% discount price. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. As of September 30, 2021, and through the date of this report, the principal and interest balance totaling $232,460 is outstanding. The Company has a verbal agreement with Auctus to extend the maturity of the note.

On May 20, 2020, the Company and GS Capital Partners, LLC entered into a 10% convertible note in the aggregate principal of $165,000 due on February 20, 2021. The note can be converted into shares of common stock of the Company at any time after the issue date, at a price of $0.01 per share. During the first three months ended June 30, 2021, the noteholder converted $50,000 of principal plus accrued interest into 5,368,493 shares of common stock. The remaining principal and accrued interest of the note was paid in full on March 10, 2021.

On June 29, 2020, the Company and Power Up Lending Group entered into a securities purchase agreement for a 10% Convertible Promissory Note in the aggregate principal of $53,000 due on June 29, 2021. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. On January 15, 2021 the Company, paid off the convertible note payable.

On August 5, 2020, the Company and Adar Alef, LLC entered into a security agreement for an 8% convertible note in the aggregate principal of $150,000 due August 5, 2021. The note is convertible into shares of the Company’s common stock at any time after the 9^thmonthly anniversary of the issuance date. The “Conversion Price” shall mean 55% multiplied by the Market Price (as defined herein), representing a discount rate of 45%. “Market Price” means the lowest traded price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The Company is required to maintain a common share reserve of 62,337,000 shares. On May 6, 2021, the convertible note and accrued interest, with a redemption fee for a total of $238,950, was paid off by the CEO of the Company.

On August 17, 2020, the Company and Harbor Gates Capital, LLC entered into a securities agreement for a 10% Convertible Note in the aggregate principal of $165,000 due August 17, 2021. The note carries original issue discount or $15,000. The note can be converted (180) days following the issuance date of the note. The conversion price is equal to the Variable Conversion price which is defined as 60% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. The Note and accrued interest totaling $272,250.00 paid by the Company on May 28,2021

On August 25, 2020, the Company and Power Up Lending Group entered into a securities purchase agreement for a 10% Convertible Note in the aggregate principal of $103,000 due on August 25, 2021. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. On February 25, 2021, the Company estimated the fair value of the conversion feature derivative embedded in the debenture at issuance at $151,000, based on weighted probabilities of assumptions. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.06 at issuance date; a risk-free interest rate of 0.06% and expected volatility of the Company’s common stock, of 162.43%, and the various estimated reset exercise prices weighted by probability. This plus the fair value of the warrants resulted in the calculated fair value of the debt discount being greater than the face amount of the debt, and the excess amount of $48,000 was immediately expensed as interest expense. On February 24, 2021 the convertible note and accrued interest, with a redemption fee for a total of $151,311, was paid off by the CEO of the Company.

On October 6, 2020, the Company and Power Up Lending Group entered into a securities purchase agreement for a 10% Convertible Note in the aggregate principal of $75,000 due on August 25, 2021. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. On March 6, 2021, the Company estimated the fair value of the conversion feature derivative embedded in the debenture at issuance at $81,198, based on weighted probabilities of assumptions. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.04 at issuance date; a risk-free interest rate of 0.07% and expected volatility of the Company’s common stock, of 171.53%, and the various estimated reset exercise prices weighted by probability. This resulted in the calculated fair value of the debt discount being greater than the face amount of the debt, and the excess amount of $6,198 was immediately expensed as interest expense. On April 9, 2021, the convertible note and accrued interest, with a redemption fee, for a total of $110,120, was paid off by the Company on April 9, 2021.

On May 10, 2019, the Company and GHS Investments LLC entered into a securities agreement for a 10% Convertible Note in the aggregate principal of $335,000 due on February 10, 2020. The note carries original issue discount or $35,000. The note is convertible into shares of common stock of the Company. The “Conversion Price” shall mean 60% multiplied by the Market Price (as defined herein), representing a discount rate of 40%. “Market Price” means the lowest Traded Price for the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. The Company is required to maintain a common share reserve of not less than three times the number of shares that is actually issuable upon full conversion of the note. The purchaser will also receive warrants to purchase 5,000,000 shares of GDSI common stock at $.01/share. Warrants will have a three-year term to exercise. The Convertible Note is personally guaranteed by William Delgado, CEO. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. As of September 30, 2021, and December 31, 2020, and through the date of this report, the principal balance totaling $833,760 including approximately an additional $225,000 added to principal for an open-ended extension of the due date of the note, is outstanding. In relation to the extension, the Company is required to issue 1,000,000 warrants each month, and pay $25,000 per month. As of September 30, 2021 the Company has issued 21,000,000 warrants, with a fair value of $891,000 at issuance, with are classified in warrant liability.Notes Payable

During January 2015, the Company entered into a one-year $78,750 convertible note payable with LG Capital Funding (LG). The note bears interest at 8% per annum and is convertible at any time at the option of LG into shares of our common stock at a conversion price equal to a 40% discount of the lowest closing bid price for 20 prior trading days including the notice of conversion date. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve four times the potential number of shares of common stock issuable upon conversion, or ~~18,866,092 shares~~157,974,360 and ~~157,874,360 shares~~82,557,576 at ~~September 30, 2021, and~~ December 31, 2020 and 2019, respectively. The Company defaulted on the note in January 2016. Additionally, as a result of declines in the fair value of the Company’s common stock, from time to time the Company did not have sufficient authorized shares to maintain this required four times share reserve. Accordingly, the note holder had the right to accelerate the repayment of the note and unpaid interest. In addition, LG has the right to require that additional shares and/or monies be paid in connection with the defaults. During December 2017, in settlement of default, the Company and LG entered into a Convertible Note Redemption Agreement under which the Company was to repay $68,110, $39,921 in unpaid principal outstanding at December 31, 2017 and $28,189 in accrued interest, in five payments through April 2018. Through April 2018, the Company repaid $6,500 of principal under the Convertible Note Redemption Agreement. The Company defaulted on the Convertible Note Redemption Agreement in April 2018 and the $28,189 in accrued interest was converted to principal. As of ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020,~~2021, and through the date of this report, the principal balance totaling $48,610 is ~~outstanding~~outstanding. and remains in default.

During January 2015, the Company entered into a two-year convertible note payable for up to $250,000 with JMJ Financial (JMJ), of which $110,000 was funded between January and April 2015. The note was issued with an original issue discount of 10% of amounts funded, had a one-time 12% interest charge as it was not repaid within 90 days of the funding date, and is convertible at any time at the option of JMJ into shares of our common stock at the lesser of $0.075 per share or 60% of the average of the trading price in the 25 trading days prior to conversion. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve 26,650,000 shares of common stock. JMJ had the option to finance additional amounts up to the balance of the $250,000 during the term of the note. The Company defaulted on the note during January 2017. During December 2017, in settlement of default, the Company and JMJ entered into a Repayment Agreement under which the Company was to repay $84,514, $69,070 in unpaid principal outstanding at December 31, 2017 and $15,444 in accrued interest, in four payments through May 2018. Through May 2018, the Company repaid $25,000 of principal under the Repayment Agreement. The Company defaulted on the Repayment Agreement in May 2018 and the $15,444 in accrued interest was converted to principal. As of ~~September~~December 31, 2021, and through the date of this report, the principal balance totaling $59,514 is outstanding. and remains in default.

On April 7, 2020, the Company entered into a convertible promissory note arrangement with Auctus Fund, LLC in the principal amount of $197,000. The principal amount of the note with interest at 12% is due on February 7, 2021. The note is convertible into shares of The Company’s common stock. The conversion price shall equal the lessor of (i) Current Market price or (ii) Variable Market price as defined as Market Price less a 50% discount price. As of December 31, 2021, and through the date of this report, the principal balance totaling $197,000. The note is past the maturity date and has not been repaid through the date the financial statements were issued.

On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of March 31, 2022, and December 31, 2021, and through the date of this report, the principal balance totaling $1,133,145 is outstanding. On March May 19, 2022, The Company and Leonite Capital agreed to an extension of the Note’s Maturity date to February 25, 2023. In consideration the Company agreed to an extension fee of 20% of the outstanding Balance at May 19, 2022, and the fixed conversion price was amended to $0.01 from $$0.06.

On April 1, 2021, the Company received the first tranche of $1,142,857 from GS Capital, LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period.

The Company received the second tranche as follows; May 24, 2021, $796,000, July 15, 2021, $90,000, and July 21, 2021, $208,500. As of March 31, 2022, and December 31, 2021, and through the date of this report, the principal balance totaling $2,244,846 and $2,285714 respectively is outstanding. On May 17, 2022, the Company and GS Capital Partners, LLC into an agreement that the maturity date of all four tranches has been extended by six months,

On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% promissory note in the aggregate principal of $251,625, with a maturity date of June 7, 2022. The note included an original issuance discount (“OID”) of $22,875, for a purchase price of $228,750. The interest was applied as a one- time interest charge upon the issuance date, in the amount of $20,130, recognized in accrued interest. The monthly payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company is required at have authorized and reserved four times the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $03, with a 3-year term. As of March 31,2022, and December 31, 2021, and through the date of this report, the principal balance totaling $75,488 and $150,975 respectively is outstanding.

On August 5, 2020, the Company and Adar Alef, LLC entered into a security agreement for an 8% convertible note in the aggregate principal of $150,000 due August 5, 2021. The note is convertible into shares of the Company’s common stock at any time after the 9^thmonthly anniversary of the issuance date. The “Conversion Price” shall mean 55% multiplied by the Market Price (as defined herein), representing a discount rate of 45%. “Market Price” means the lowest traded price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The Company is required to maintain a common share reserve of 62,337,000 shares. As of March 31, 2021, the principal balance totaling $150,000 is outstanding. On May 6, 2021, the convertible note, and accrued interest, with a redemption fee for a total of $238,950, was paid off by the CEO of the Company.

On August 17, 2020, the Company and Harbor Gates Capital, LLC entered into a securities agreement for a 10% Convertible Note in the aggregate principal of $165,000 due August 17, 2021. The note carries original issue discount or $15,000. The note can be converted (180) days following the issuance date of the note. The conversion price is equal to the Variable Conversion price which is defined as 60% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. As of March 31, 2021, and December 31, 2020, and through the date of this report, the principal balance totaling ~~$59,514~~$165,000 is ~~outstanding~~outstanding. The note was paid off by The Company on May 28, 2021.

On October 6, 2020, the Company and ~~remains~~Power Up Lending Group entered into a securities purchase agreement for a 10% Convertible Note in ~~default.~~the aggregate principal of $75,000 due on August 25, 2021. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and was accounted for as a derivative liability on the date the note became convertible. On March 6, 2021, the Company estimated the fair value of the conversion feature derivative embedded in the debenture at issuance at $115,000, based on weighted probabilities of assumptions. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.04 at issuance date; a risk-free interest rate of 0.07% and expected volatility of the Company’s common stock, of 171.53%, and the various estimated reset exercise prices weighted by probability. This resulted in the calculated fair value of the debt discount being greater than the face amount of the debt, and the excess amount of $40,000 was immediately expensed as interest expense. On April 9, 2021, the convertible note, and accrued interest, with a redemption fee, for a total of $110,120, was paid off by the CEO of the Company.

On December 10, 2021, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $128,750, due on December 10, 2022. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of March 31, 2022, and December 31, 2021, and through the date of this report, the principal balance totaling $128,750.00 is outstanding.

On February 3, 2022, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $103,750, due on February 3, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of March 31, 2022, and through the date of this report, the principal balance totaling $103,750.00 is outstanding.

The Company entered into two consulting agreements (see Note 5) in May 2016, for services to be provided in connection towards the resolution of the Rontan lawsuit (below). The consulting agreements includes a monthly retainer payment of $10,000 to each consultant. The agreement also includes consideration of 5,000,000 shares of restricted common stock of the Company, plus a 5% cash consideration of the Resolution Progress Funding, (defined as upon the retention of legal counsel and receipt of funding for the litigation), as of the Resolution Progress Funding date and 10,000,000 shares of restricted common stock of the Company and a 5% cash consideration of the Resolution Funding amount (defined as a settlement or judgement in favor of the Company by Rotan), at the Resolution Funding date. The Resolution Progress funding was met on December 22, 2017.

On March 1, 2019, the Company entered into a consulting agreement with the former owner of HarmAlarm. The agreement commenced on March 1, 2019 and shall continue for a period of thirty-six (36) months. The agreement may only be terminated by either incapacitation or death of consultant or for cause with ten (10) days written notice. During the term of the agreement consultant will be paid at a rate of $5,000 per month.

On March 1, 2019, the Company entered into a consulting agreement with a former key employee of HarmAlarm. The agreement commenced on March 1, 2019 and shall continue for a period of thirty-six (36) months. The agreement may only be terminated by either incapacitation or death of consultant or for cause with ten (10) days written notice. During the term of the agreement consultant will be paid an hourly rate of $50.00 per hour.

Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A.

Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”) and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date.

The purchase price shall consist of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date.

Under the terms of a Finders Fees Agreement dated April 14, 2014, we have agreed to pay RLT Consulting Inc., a related party, a fee of 2% (two percent) of the Transaction Value, as defined in the agreement, of Rontan upon closing. The fee is payable one-half in cash and one-half in shares of our common stock.

The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, as well as the ability to acquire 100% of the outstanding stock of Rontan at a price of $200 million BR, and the Company can acquire 100% of all real estate held by Rontan.

Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion.

Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets.

Subsequent to December 31, 2015, on April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions to closing, which were waivable by us,) and advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA.

On January 31, 2018, we announced that we initiated a lawsuit for damages against Grupo Rontan Metalurgica, S. A, (“Rontan”) and that company’s controlling shareholders, Joao Alberto Bolzan and Jose Carlos Bolzan. The action has been filed in the United States District Court for the Southern District of Florida. The complaint alleges that Rontan is wholly-owned by Joao Bolzan and Jose Bolzan. In the complaint, we further allege that Rontan and its shareholders improperly terminated a Share Purchase and Sale Agreement (the “SPA”) by which we were to acquire whole ownership of Rontan.

On February 5, 2018, United States District Court Southern District of Florida filed a Pretrial Scheduling Order and Order Referring Case to Mediation dated February 5, 2018 for the Company’s lawsuit against Grupo Rontan Electro Metalurgica, S.A., et al. The Case No. is 18-80106-Civ-Middlebrooks/Brannon. The court has issued a schedule outlining various documents and responses that are to be delivered by the parties as part of the discovery plan.

On April 25, 2018, the Note of Filing Proposed Summons was completed by the Company. On April 26, 2018, a summons was issued to Grupo Rontan Electro Metalurgica, S.A. Also, on May 15, 2018, the Company filed a motion for Issuance of Letters Rogatory.

On or about January 31, 2019, Defendants filed a Motion to Dismiss for Failure to State a Claim for failure to fulfill conditions precedent in the consummation of the contract in question. Defendants filed a Motion to Dismiss challenging jurisdiction, venue, and forum nonconvenes. On or about May 21, 2019, the Court denied their motions to dismiss for lack of personal jurisdiction, improper venue and forum nonconvenes. The court granted their Motion to Dismiss for Failure to State a Claim for failure to fulfill conditions precedent in the consummation of the contract in question but, granted leave to amend. On or about June 7, 2019, counsel filed an amended complaint. On or about June 21, 2019, defendants answered the amended complaint. The litigation moved from the pleading stage to discovery. The Company and Rontan/Bolzans entered into court order mediation on November 7, 2019. (i) Motion to set aside Default Judgement (ii) Motion for hearing on damages. ~~On February~~

Burr Foreman, the Company’s counsel on the previously dismissed case regarding NACSV, has filed a lawsuit for fees in the past due amount of $113,503. The Company was not served with the lawsuit and has paid Burr Forman $100,000 on March 3, ~~2020,~~2021 and made the U.S. District Court awarded the Company Specific Performance (Acquisition of the Plant in Tauti, Brazil) and incidental damages of approximately $192,000,000. On August 16, 2021, the court awarded the Company an additional $2,086,233 in legal fees and costs. The defendants have filed an intent to appeal the awards, but as of this date have not submitted any filings or briefs.final payment on April 9, 2021.

On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 shares of our common stock for issuance pursuant to awards thereunder, including options, stock appreciation right, restricted stock, restricted stock units, performance awards, dividend equivalents, or other stock-based awards. The Plan is intended as an incentive, to retain in the employ of the Company, our directors, officers, employees, consultants and advisors, and to attract new officers, employees, directors, consultants and advisors whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries.

In accordance with the ACS 718, Compensation – Stock Compensation, awards granted are valued at fair value at the grant date. The Company recognizes compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. The Company recognizes the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. The Company has not capitalized any portion of its stock-based compensation.

As of ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020,~~2021, we have outstanding 13,650,002 stock options - all of which are fully vested stock options that were granted to directors, officers and consultants. The outstanding stock options are exercisable at prices ranging from $~~0.006~~$0.006 to $~~0.64~~$0.64 and expire between February 2024 and December 2025, for an average exercise price per share of $0.60 and an average remaining term of ~~4.6~~3.9 years as of ~~June 30, 2021.~~March 31, 2022.

During the ~~three and six-month~~three-month period ended ~~September 30, 2021,~~March 31, 2022, and the year ended December 31, ~~2020~~, 2021, we did not recognize any stock-based compensation cost related to the outstanding stock options. The intrinsic value of options outstanding as of ~~September30, 2021,~~March 31, 2022, and December 31, ~~2020~~2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the option multiplied by the number of options outstanding.

On October 10, 2014, we granted an employee 1 million RSU’s convertible into 1 million shares of the Company’s common stock, with a grant date fair market value of $100,000. The grant was made under our 2014 Equity Incentive Plan. 333,333 RSU’s will vest in respect of each calendar year (commencing January 1 and ending December 31) of the Company from 2015 through 2017 if the Company has achieved at least 90% of the total revenue and EBITDA midpoint targets set forth in the agreement. If less than 90% of the target is achieved in respect of any such fiscal year, then the number of RSU’s vesting for that fiscal year shall be 333,333 times the applicable percentage set forth in the agreement; provided that, if the Company shall exceed 100% of the revenue and EBITDA midpoint +-target for the 2018 or 2017 calendar year, and shall have failed to reach 90% of the target for a prior calendar year, the excess over 100% shall be applied to reduce the deficiency in the prior year(s), and an additional number of RSU’s shall vest to reflect the increased revenue for such prior calendar year. Any such excess shall be applied first to reduce any deficiency for the 2015 calendar year and then for the 2016 calendar year. The vesting of the RSU’s shall be effective upon the issuance of the audited financial statements of the Company for the applicable calendar year and shall be based upon the total revenue and EBITDA of the acquired companies as reflected in such financial statements.

The aggregate intrinsic value of the restricted stock grant was $0 as of ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020.~~2022.

The Company provides for a valuation allowance when it is more likely than not that they will not realize a portion of the deferred tax assets. The Company has established a valuation allowance against their net deferred tax asset due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, they have not reflected any benefit of such deferred tax assets in the accompanying financial statements.

The Company has reviewed all income tax positions taken or that are expected to be taken for all open years and determined that their income tax positions are appropriately stated and supported for all open years. The Company is subject to U.S. federal income tax examinations by tax authorities for years after 2011 due to unexpired net operating loss carryforwards originating in and subsequent to that year. The Company may be subject to income tax examinations for the various taxing authorities which vary by jurisdiction.

The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statements of ~~operations..~~operations. As of March 31, 2022.

The Company files income tax returns in the U.S. federal jurisdiction and the various states in which they operate. The former members of NACSV are required to file separate federal and state tax returns for NACSV for the periods prior to our acquisition of NACSV. The Company files consolidated tax returns for subsequent periods. The Company has not filed their U.S. federal and certain state tax returns since 2014 and currently do not have any examinations ongoing. Tax returns for the years 2012 onwards are subject to federal, state or local examinations.

~~The Due to Officer is due on demand, does not bear or accrue interest and is unsecured. On February 24,~~During 2021 ~~the CEO, William J.~~Mr. Delgado paid off ~~a convertible~~approximately $390,000 of the Company’s debt. The Company paid Mr. Delgado approximately $1,326,000 which included repayment for amounts paid for the note ~~plus accrued interest~~ and ~~redemption fees (see Note 5), for a total payment of $151,211. On May 12, 2021, he paid off a convertible note plus accrued interest and redemption fees, for a total payment of $238,950,~~

~~The balance owing to the Officer in the amount of $643,553, was paid off during the three months ended September 30, 2021.~~compensation. The amount owing for Due to officer was $~~253,291~~3,281 and $50,000, as of March 31, 2022, and December 31, ~~2020.~~

~~During the three months ended June 30,~~ 2021, the Company paid the CEO a bonus compensation of approximately $820,000, which is recognized in Selling, general and administrative expenses in the accompanying Consolidated Statement of Operations. The amount owing for Due to officer was $0, as of September 30, 2021.respectively.

During the year ended December 31, 2020, the Company advanced Eco-Growth Strategies, Inc., a related entity, $70,710 to cover administrative costs. During the three and six month period ended June 30, 2021, Eco-Growth Strategies, Inc. repaid the advance from December 31, 2020 and the additional $270,000 that the Company advanced. During the three month period ended September 30th, 2021 the Company advanced an additional $ $137,681 for administrative costs

As of ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020,~~2021, we had ~~$60,000 and $64,481~~$0 payable to William J. Delgado and ~~$85,834~~$100,834 and ~~$77,834~~$90,834 payable to Jerome Gomolski, respectively. Accrued compensation is included in Accrued expenses.

As of ~~September 30, 2021,~~March 31, 2022, and December 31, ~~2020,~~2021, the Company had a note payable to RLT Consulting and a consulting agreement see (see Note 5). RLT Consulting is owned by Ross Trevino, a Vice President of the Company.

During August 2017, Dragon Acquisitions, an entity owned by William Delgado, a related party, and an individual lender entered into a Promissory Note agreement for $20,000 as well as $2,000 in interest to accrue through maturity on August 31, 2018, for a total of $22,000 due on August 31, 2018. Dragon Acquisition assumed payment of a payable of the Company and the Company took on the note. The Company defaulted on the note at maturity in August 2018. The lender has extended the maturity date to December 31, 2021. The $22,000 note remained outstanding as of March 31, 2022, and December ~~31, 2020 and September 30, 2021~~31,2021, and through the date of this report.

The June 2018 note bears a personal guarantee by William Delgado, the Chief Executive Officer of the Company. As further security for the note, Mr. Delgado has also pledged the 1,000,000 Convertible Preferred Shares of the Company that he owns, as well as 5,000,000 common shares of SHMP, another public company in which Mr. Delgado is a director and Chief Financial Officer.

~~Prepaid expense represents the cost of an airplane purchased by the Company and transferred to Valley Air Express, a related entity, in exchange for flight hours. The prepaid expense of $520,000~~ ~~will be amortized over the flight hours used in the software development of the Pilot Assisted Landing System. See Note 1.~~

On March 25,2022, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 12% Convertible Note in the aggregate principal of $258,638, due on March 25, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The note was funded on April 4, 2023.

On ~~October 21, 2021~~May 17, 2022, the Company ~~entered~~and GS Capital Partners, LLC into an agreement ~~with GHS Investments LLC. Pursuant~~that the maturity date of all four tranches of the Note dated March 21, 2021, has been extended by six months,

On March May 19, 2022, The Company and Leonite Capital agreed to an extension of the ~~agreement~~Note’s Maturity date to February 25, 2023. In consideration the Company ~~issued~~ ~~25,500,000~~ ~~shares on October 21, 2021 in satisfaction~~agreed to an extension fee of 20% of the ~~Convertible Promissory note dated~~outstanding Balance as of May ~~10, 2019 with a balance of $8,333,760~~ ~~at September 31, 2021.~~ 19, 2022, and the fixed conversion price was amended to $0.01 from $$0.06.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q includes a number of forward-looking statements that reflect management’s current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 19, 2021, any of which may cause our company’s or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in our forward-looking statements. These risks and factors include, by way of example and without limitation:

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or performance. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the SEC. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in the future operating results over time, except as required by law. We believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions.

As used in this Quarterly Report on Form 10-Q and, unless otherwise indicated, the terms “GDSI,” “Company,” “we,” “us,” and “our” refer to Global Digital Solutions, Inc. and our wholly owned subsidiaries GDSI Florida, LLC, HarmAlarm and North American Custom Specialty Vehicles, Inc. Unless otherwise specified, all dollar amounts are expressed in United States dollars.

We were incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation. The merger was treated as a recapitalization of Global Digital Solutions, Inc., and Creative changed its name to Global Digital Solutions, Inc. (“GDSI”). We are focused in the area of cyber arms technology and complementary security and technology solutions. On October 22, 2012, we entered into an Agreement of Merger and Plan of Reorganization to acquire 70% of Airtronic USA, Inc. (“Airtronic”), a then debtor in possession under chapter 11 of the Bankruptcy Code once Airtronic successfully reorganized and emerged from bankruptcy (the “Merger”). During the period from October 2012 through November 2013, we were actively involved in the day to day management of Airtronic pending the completion of the Merger. The Merger did not occur and we ceased involvement with Airtronic. In December 2012 we incorporated GDSI Florida LLC (“GDSI FL”), a Florida limited liability company. Except for the payment of administrative expenses on behalf of the Company, GDSI FL has no business operations. In January 2013, we incorporated Global Digital Solutions, LLC, a Florida limited liability company. In November 2013, we incorporated GDSI Acquisition Corporation, a Delaware corporation. On June 16, 2014, we acquired North American Custom Specialty Vehicles, LLC, into GDSI Acquisition Corporation, and changed the latter’s name to North American Custom Specialty Vehicles, Inc. (“NACSV”). In July 2014, we announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead our efforts overseas. In March of 2019, we acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA has developed a system known as Pilot Assisted Landing Systems (PALS). We believe the precision and robustness of PALS has generated a host of new applications mainly through “landing trajectory” optimization which provides additional safety margin against weather related hazardous conditions, like wind shear, wake turbulence, icing, as well as low ceilings and fog.

We are engaged in the development of proprietary aviation technology. We are also looking to develop an automotive technology company currently in Brazil. We have been in litigation concerning Rontan Metallurgica in Sao Paulo, Brazil and have been awarded a default judgment regarding the acquisition of the company. We are currently awaiting final damages in the case.

Comparison of the Three Months Ended ~~September 30, 2021~~March 31, 2022, to the Three Months Ended ~~September 30, 2020~~March 31, 2021

There was no revenue for the three months ending ~~September 30, 2021~~March 31, 2022, or ~~September 30, 2020.~~March 31, 2021.

Our operating expenses for the three months ended ~~September30, 2021~~March 31, 2022, are summarized as follows in comparison to the three months ended ~~September 30, 2020:~~March 31, 2021:

Operating expenses for the three months ended ~~September 30, 2021~~March 31, 2022, decreased by ~~$ 46,000 $~~$145,073, or ~~18%~~34%, as compared with the same period in ~~2020. The decrease is due primarily to reduction in legal fees of $62,000.~~

~~The professional fees, are for services provided by an attorney and accounting and auditing services. The decrease is due primarily to reduction in legal fees of $62,000.~~

~~Comparison of the Nine Months Ended September 30, 2021 to the Nine Months Ended September 30, 2020~~

~~There was no revenue for the nine months ending September 30, 2021 or September 30, 2020.~~

~~Our operating expenses for the nine months ended September 30, 2021 are summarized as follows in comparison to the nine months ended September 30, 2020:~~

~~Operating expenses for the nine months ended September 30, 2021 increased by $1,009,148, or 126%, as compared with the same period in 2020.~~2021. The overall change in operating expenses is mainly due to to the ~~bonus paid to the CEO of approximately $820,000, as well as the increase~~decrease in consulting ~~services during the nine months ended September 30, 2021~~services..

As of ~~September 30, 2021,~~March 31, 2022, we had cash on hand of approximately ~~$2,003~~$3,500 and a working capital deficiency of approximately ~~$13,343,720~~$11,603,000 as compared to cash on hand of approximately ~~$300~~$99,000 and a working capital deficiency of approximately ~~$17,403,000~~$11,159,000 as of December 31, ~~2020.~~2021. The decrease in working capital deficiency for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022, is mainly due to the decrease in cash on hand of $95,000, increase in accrued expenses, of $210,000, increase in the ~~derivative liability, resulting from the change in~~ fair value of the derivatives of $162,000, increase in Convertible Notes Payable of $298,000, an increase in Notes Payable of $137,000 offset by ~~the recognition of~~decrease in the warrant liability ~~discussed in further detail below, in current liabilities.~~of $178,00 and decrease od Due to officer of $47,000.

Our working capital deficiency as of ~~September 30,~~March 31, 2021, in comparison to our working capital deficiency as of December 31, 2020, can be summarized as follows:

The increase in current assets is mainly due to the increase of approximately $135,000 in prepaid expenses., The decrease in current liabilities is primarily due to the decrease in the derivative liability, resulting from the change in fair value of the derivatives of approximately $7,200,000 less the approximately $1,026,000 reclassed to equity upon pay off of the related convertible notes, offset by the recognition of the $2,398,000 in warrant liability for new warrants issued in connection with a new convertible debenture in the first and second quarter of 2021, and approximately $900,000 resulting from the change in fair value of the warrants.

During the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020,~~ our sources and uses of cash were as follows:

Net cash used in operating activities was approximately ~~$1,890,000~~$120,000 for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, primarily due to the net ~~income~~loss of approximately ~~$2,042,000~~$930,000 which was partially offset by non-cash expenses of approximately ~~$6,400,000~~$810,000 related to an ~~decrease~~increase in the fair value of derivative liabilities, amortization of debt discount, Loss on conversion of convertible notes payable, There was additionally actual cash used by changes in the levels of operating assets and ~~$894,000~~liabilities, primarily as a result of decreases in accrued interest and amount due to officer.

Net cash used in operating activities was approximately $492,000 for the ~~change~~three months ended March 31, 2021, primarily due to the net income of $3,721,651 which was partially offset by non-cash expenses of approximately $4,119,000 related to an increase in the fair value of ~~the warrant liability,~~derivative liabilities, amortization of debt discount, interest expense, and the change in fair value of the warrant liability recognized this period. There was additionally actual cash used by changes in the levels of operating assets and liabilities, primarily as a result of decreases in accrued interest and amount due to officer.

Net cash used in operating activities was $(1,531,845) for the nine months ended September 30, 2020, primarily due to net loss of $(3,403,256), which was partially offset by non-cash expenses of approximately $(236,206) related to change in fair value of derivative liabilities, the amortization of debt discount of $654,584, and interest expense, and $(314,591) cash used in the levels of operating assets and liabilities.

During the ~~nine~~three months ended ~~September 30,~~March 31, 2022, and 2021, ~~and 2020,~~ net cash used in investing activities was ~~approximately $67,000 for advances to related party in 2021 and $233,548 in 2020 for cash used for software development costs.~~$0.

Net cash provided by financing activities for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022, was ~~approximately $1,959,000,~~$24,512, which was due to ~~$3,275,000~~$100,000 of proceeds from debt financings, offset by ~~approximately $1,316,000~~$75,488 of repayments of ~~notes payable and~~ convertible ~~notes and advances from partner~~notes.

~~During the nine months ended September 30, 2020,~~Net cash provided by financing activities ~~consisted~~for the three months ended March 31, 2021, was $817,500, which was due to $1,088,500 of proceeds from ~~convertible notes payable of $1,077,000~~ debt financings, offset by ~~payment on~~$271,000 of repayments of convertible ~~notes payable of $(571,750), proceeds of $803,125 from notes payable, proceeds from exercise of warrants of $60,000.~~notes.

On ~~January 15, 2021,~~February 3, 2022, the Company and ~~Power Up~~Sixth Street Lending ~~Group~~LLC, entered into a ~~securities~~security purchase agreement for a ~~10% convertible note~~8% Convertible Note in the aggregate principal of ~~$88,500~~$103,750, due on ~~January 15, 2022.~~February 3, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the ~~variable conversion~~Variable Conversion price which is defined as ~~61%~~65% of the ~~market price~~Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the ~~conversion~~Conversion date. ~~The conversion feature meets the definition~~As of a derivative and therefore requires bifurcation and will be accounted for as a derivative liability on the date the note becomes convertible. On July 13, 2021, the Company paid off the note, plus accrued interest and redemption fees, for a total payment of $130,078.

On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be the twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request. On March 1, 2021, the Company received the first tranche of $1,000,000. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $1,015,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As September 30, 2021,31, 2022, and through the date of this report, the principal balance totaling ~~$1,142,875~~$103,750.00 is outstanding.

On March 25, 2021, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be the twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request. On April 1, 2021, the Company received the first tranche of $1,000,000. In connection with the note, the Company will issue 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $917,000. The Company also will issue 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $184,000.

The accompanying financial statements have been prepared in conformity with ~~accounting principles generally accepted in the United States of America (“GAAP”),~~GAAP, assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has sustained losses and experienced negative cash flows from operations since inception, and for the ~~nine~~three months ended ~~September 30, 2021, while~~March 31, 2022, it had a net ~~income~~loss of approximately ~~$2,042,000,~~$930,082 which was mostly the result of the ~~change in fair value~~amortization of ~~the derivative liability, the~~Original issue discount and Selling and Administrative expenses. The Company used net cash of ~~approximately $1,890,000~~$119,773 to fund operating activities at ~~September 30, 2021,~~March 31, 2022, had an accumulated deficit of approximately ~~$49,518,000,~~$50,270,000, and a working capital deficit of approximately ~~$13,344,000.~~$11,602,000. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of the financial statements. The Company has funded ~~its~~their activities to date almost exclusively from equity and debt financings.

We will require additional funds to implement our growth strategy for our business. In addition, while we have received capital from various private placements that have enabled us to fund our operations, these funds have been largely used to develop our processes, although additional funds are needed for other corporate operational and working capital purposes. Subsequent to period end we have received funding of ~~$1,000,000~~$200,000 from ~~the first tranche of~~ a convertible note entered into in March ~~2021.~~2022. However, not including funds needed for capital expenditures or to pay down existing debt and trade payables, we anticipate that we will need to raise an additional $2,500,000 to cover all of our operational expenses over the next 12 months, not including any capital expenditures needed as part of any commercial scale-up of our equipment. These funds may be raised through equity financing, debt financing, or other sources, which may result in further dilution in the equity ownership of our shares. There can be no assurance that additional financing will be available to us when needed or, if available, that such financing can be obtained on commercially reasonable terms. If we are not able to obtain the additional necessary financing on a timely basis, or if we are unable to generate significant revenues from operations, we will not be able to meet our other obligations as they become due, and we will be forced to scale down or perhaps even cease our operations.

We do not believe that inflation has had a material impact on our business, revenues or operating results during the periods presented.

Our significant accounting policies are more fully described in the notes to our unaudited condensed consolidated financial statements included herein for the quarter ended ~~September 30, 2021~~March 31, 2022, and in the notes to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021, as filed with the SEC on April ~~19, 2021.~~20,2022

The fair value measurement guidance clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in the valuation of an asset or liability. It establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under the fair value measurement guidance are described below:

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or ~~liabilities;~~liabilities.

Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or

Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at dates of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the periods. Our significant estimates and assumptions include the recoverability and useful lives of long-lived assets, the fair value of our common stock, stock-based compensation, warrants issued in connection with notes payable, derivative liabilities and the valuation allowance related to our deferred tax assets. Certain of our estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to us and general economic conditions. It is reasonably possible that these external factors could have an effect on our estimates and could cause actual results to differ from those estimates.

Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at ~~June 30, 2021,~~March 31, 2020, and December 31, 2020. The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.

~~In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion~~Any new and ~~Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts~~recently adopted accounting pronouncements are more fully described in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entitiesNote 2 to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The Company is currently evaluating the impact that ASU 2020-06 may have on itsour unaudited condensed consolidated financial statements ~~and related disclosures.~~herein for the quarter ended March 31, 2021.

~~Management is evaluating other new accounting pronouncements but doesn’t expect them to have material impact on our financial position or results of operations.~~

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Not Applicable. As a smaller reporting company, we are not required to provide the information required by this Item.

We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. In designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives.

Under the supervision and with the participation of our management, including our principal executive officer, who is also our principal financial officer, we are required to perform an evaluation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act, as of ~~June 30, 2021.~~March 31, 2022. Management has not completed such evaluation and, as such, has concluded that our disclosure controls and procedures were not effective to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive officer, who is also our principal financial officer, as appropriate to allow timely decisions regarding required disclosures. As a result of the material weakness in internal controls over financial reporting described below, we concluded that our disclosure controls and procedures as of ~~September 30, 2021~~March 31, 2022, were not effective.

Management and the Company’s consolidated subsidiaries are responsible for establishing and maintaining adequate internal control over financial reporting. The Company’s internal control over financial reporting is a process designed under the supervision of its principal executive and principal financial officer and effected by the Company’s Board of Directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of its unaudited condensed consolidated financial statements for external reporting purposes in accordance with GAAP.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of the Company’s internal control over financial reporting as of ~~September 30, 2021~~March 31, 2022, based on the framework established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management has determined that the Company’s internal control over financial reporting as of ~~June 30, 2021~~March 31, 2022, was not effective.

A material weakness, as defined in the standards established by the Sarbanes-Oxley, is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim unaudited condensed consolidated financial statements will not be prevented or detected on a timely basis.

The ineffectiveness of the Company’s internal control over financial reporting was due to the following material weaknesses:

Other than described above there have been no changes in our internal control over financial reporting that occurred during our first quarter of ~~2021~~2022 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

An investment in the Company’s common stock involves a number of very significant risks. You should carefully consider the risk factors included in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021, as filed with the SEC on April ~~19, 2021,~~21, 2022, in addition to other information contained in our reports and in this quarterly report in evaluating the Company and its business before purchasing shares of our common stock. Except as set forth below, there have been no material changes to our risk factors contained in our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021. The Company’s business, operating results and financial condition could be adversely affected due to any of those risks.

On or about January 31, 2019, Defendants filed a Motion to Dismiss for Failure to State a Claim for failure to fulfill conditions precedent in the consummation of the contract in question. Defendants filed a Motion to Dismiss challenging jurisdiction, venue, and ~~forum nonconvenes~~~~. On or about May 21, 2019, the Court denied their motions to dismiss for lack of personal jurisdiction, improper venue and~~ ~~forum nonconvenes~~. The court granted their Motion to Dismiss for Failure to State a Claim for failure to fulfill conditions precedent in the consummation of the contract in question but, granted leave to amend. On or about June 7, 2019, counsel filed an amended complaint. On or about June 21, 2019, defendants answered the amended complaint. The litigation moved from the pleading stage to discovery. The Company and Rontan/Bolzans entered into court order mediation on November 7, 2019. (i) Motion to set aside Default Judgement (ii) Motion for hearing on damages.

The following disclosures set forth certain information with respect to all securities sold by the Company during the three months ended ~~June 30, 2021~~March 31, 2022, without registration under the Securities Act:

On ~~June 7, 2021,~~February 3, 2022, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% promissory note in the aggregate principal of $251,625, with a maturity date of June 7, 2022. The note included a original issuance discount (“OID”) of $22,875, for a purchase price of $228,750. The interest was applied as a one time interest charge upon the issuance date, in the amount of $20,130, recognized in accrued interest. The monthly payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company is required at have authorized and reserved four times the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $003, with a 3-year term.

~~On March 25, 2021, the Company and GS Capital Partners~~Sixth Street Lending LLC, entered into a security purchase agreement for a ~~Prime rate plus~~ 8% Convertible Note in the aggregate principal of ~~$2,285,714.~~$103,750, due on February 3, 2023. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principalis convertible into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request. On April 1, 2021, the Company received the first tranche of $1,000,000. Upon the receipt of the first tranche, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $917,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $184,000. On May 24, 2021, the Company received the second tranche from GS Capital Partners LLC, for $796,000’ less an OID of $99,500. On May 24, 2021 the Company received the balance of the second tranche for $346,857 less an OID of $48,357

On January 15, 2021, the Company and Power Up Lending Group entered into a securities purchase agreement for a 10% convertible note in the aggregate principal of $88,500 due on January 15, 2022. The conversion price is equal to the ~~variable conversion~~Variable Conversion price which is defined as ~~61%~~65% of the ~~market price~~Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the ~~conversion~~Conversion date. The conversion feature meets the definition of a derivative and therefore requires bifurcation and will be accounted for as a derivative liability on the date the note becomes convertible. On July 13, 2021, the Company paid off the note, plus accrued interest and redemption fees, for a total payment of $130,078.

On March 1, 2021, the Company received the first tranche of $1,000,000. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of ~~September 30, 2021,~~March 31, 2022, and through the date of this report, the principal balance totaling ~~$1,142,875~~$103,750.00 is outstanding.

~~The above transactions did not involve any underwriters, underwriting discounts or commissions, or any public offering. The Company relied upon the exemption from the registration requirements~~Table of ~~the Securities Act of 1933, as amended (the “Act”) by virtue of Section 4(a)(2) thereof and/or Regulation D promulgated by the SEC under the Act.~~Contents

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

New Jersey		22-3392051
(State or other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)


777 South Flagler Drive, Suite 800 West Tower West Palm Beach, FL		33401
(Address of Principal Executive Offices)		(Zip Code)

		Page

PART I. FINANCIAL INFORMATION		3

ITEM 1.	Financial Statements	3

	Condensed Consolidated Balance Sheets as of ~~September 30, 2021~~March 31, 2022 (unaudited) and December 31, ~~2020~~2021 (unaudited)	3

	Condensed Consolidated Statements of Operations for the Three ~~and Nine~~ Months Ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ (unaudited)	4

	Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the ~~Nine~~Three Months Ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ (unaudited)	5

	Condensed Consolidated Statements of Cash Flows for the ~~Nine~~Three Months Ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ (unaudited)	6

	Notes to Condensed Consolidated Financial Statements (unaudited)	7

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23

ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	30

ITEM 4.	Controls and Procedures	30

PART II. OTHER INFORMATION		3231

ITEM 1.	Legal Proceedings	3231

ITEM 1A.	Risk Factors	3231

ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3331

ITEM 3.	Defaults Upon Senior Securities	3432

ITEM 4.	Mine Safety Disclosures	3432

ITEM 5.	Other Information	3432

ITEM 6.	Exhibits	3533

SIGNATURES		3634

	September 30, 2021			December 31, 2020
	(Unaudited)						March 31, 2022			December 31, 2021
Assets
Current Assets
Current assets
Cash	$	2,003		$	264		$	3,539		$	98,800
Prepaid Expenses		135,000			—
Total current assets		137,003			264			3,539			98,800

Other Assets
Prepaid expenses - related party		520,000			520,000
Due from related entity		137,681			70,710
Equipment, net of accumulated depreciation of $7,617 at September 30, 2021 and $5,078 at December 31, 2020		43,165			45,704
Software Development Cost		64,547			64,547
Due from related entity, (Note 9)								38,443			80,914
Prepaid Expense, (Note 9)								—			22,500
Equipment net of accumulated depreciation of $ 17,773								33,008			33,009
Software Development costs								64,547			64,547
Total other assets		765,393			700,961			135,998			200,970

Total assets	$	902,396		$	701,225		$	139,537		$	299,770

Liabilities and Stockholders’ Deficit
Current Liabilities
Current liabilities
Accounts payable	$	368,227		$	486,593		$	363,180		$	361,813
Accrued expenses		1,221,179			1,343,880			1,692,151			1,481,910
Due to officer		—			253,291
Due to Officer (Note 9)								3,281			50,000
Financed insurance policy		11,187			11,187			11,187			11,187
Derivative liability		2,122,328			9,367,159			971,000			809,000
Warrant liability		1,504,000
Convertible notes payable,net of discount $1,077,945 and $195,434 respectively		3,686,802			1,429,450
Warrant Liability								427,500			606,000
Convertible notes payable, net of discount of $ 290,693 and $652,178 respectively								3,373,940			3,310,662
Notes Payable		4,567,000			4,512,000			4,764,000			4,627,000
Total current liabilities		13,480,723			17,403,560
Total Current Liabilities								11,606,240			11,257,572

Commitments and Contingencies (Note 6)

Long term liabilities
Notes payable, net of discount $1,077,945 and $195,434 respectively.		103,125			103,125

Notes payable,								103,125			103,125
Total Liabilities		13,583,848			17,506,685			11,709,365			11,360,697

Commitments and Contingencies (Note 7)

Stockholders’ deficit
Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 issued and outstanding at September 30, 2021 and December 31, 2020, respectively	$	1,000		$	1,000
Common stock, $0.001 par value, 2,000,000,000 shares authorized 726,167,847, and 668,338,264 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively		701,863			668,338
Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 shares issued and outstanding at December 31, 2020 and 2019, respectively								1,000			1,000
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 737,263,858 and 772,012,967 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively								772,013			737,264
Additional paid-in capital		35,954,217			34,086,086			37,756,817			37,370,384
Shares payable		180,000			—
Shares Payable								180,000			180,000
Accumulated deficit		(49,518,532	)		(51,560,884	)		(50,279,658	)		(49,349,575	)
Total stockholders’ deficit		(12,681,452	)		(16,805,460	)		(11,569,828	)		(11,060,927	)
Total liabilities and stockholders’ deficit	$	902,396		$	701,225		$	139,537		$	299,770


	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2021			2020			2021			2020

Revenue	$	—		$			$	—		$	—

Operating expenses
Selling, general and administrative expenses		218,488			264,581			1,809,106			799,958

Operating loss before other (income) expense		218,488			264,581			1,809,106			799,958

Other (income) expense
Change in fair value of derivative liability		1,340,802			(3,476,526	)		(6,439,186	)		(236,206	)
Change in fair value of warrant liability		(45,000	)		—			(894,000	)		—
Amortization of debt discount		583,841			225,542			1,681,178			654,584
Interest expense		380,126			303,554			1,812,550			2,184,920
Other income		—			—			(12,000	)		—
Total other (income) expense		2,259,769			(2,957,661	)		(3,851,458	)		2,603,298

Income/(loss) from operations before provision for income taxes		(2,478,256	)		2,682,849			2,042,352			(3,403,256	)

Provision for income taxes		—			—						—

Net income/(loss)	$	(2,478,256	)	$	2,682,849		$	2,042,352		$	(3,403,256	)

Loss per common share - basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)
Loss per common share - diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)

Weighted average common shares:
Basic		698,637,958			632,690,409			698,637,958			628,559,792
Diluted		698,637,958			632,690,409			698,637,958			628,559,792

Large accelerated filer	☐o	Accelerated filer	☐o

Non-accelerated Filer	☐o	Smaller reporting company	☒x

		Emerging growth company	☐o

	March 31,			March 31,
	2022			2021
Revenues	$	—		$	—
Cost of revenues		—			—
Gross profit		—			—

Operating expenses
Selling, general and administrative expenses		280,351			425,424
Total operating expenses		280,351			425,424

Income (Loss) from operations		(280,351	)		(425,424	)

Other (income) expense
Change in fair value of derivative liability		45,000			(5,434,152	)
Change in Warrant Liability		(178,500	)		94,000
Loss on conversion of notes payable		85,241			—
Interest expense		215,757			1,048,852
Amortization of Original issue discount		482,234			156,225
Gain on settlement of accrued expenses		—			(12,000	)
Total other expense (income)		649,732			(4,147,075	)

(Loss) Income Before Income Tax		(930,083	)		3,721,651
Net (Loss) Income	$	(930,083	)	$	3,721,651

Net (Loss) Income per common share, basic and diluted	$	(0.00	)	$	0.01

Weighted average common shares outstanding, basic		648,640,637			647,441,868

Weighted average common shares outstanding, diluted		648,640,637			958,495,183


	Preferred stock				Common stock				Additional paid in			Shares		Accumulated			Total stockholders’
	Shares		Amount		Shares		Amount		Capital			Payable		deficit			deficit
	Preferred stock				Common stock				Additional paid in								Total stockholders’
	Shares		Amount		Shares		Amount		Capital			Shares Payable		Accumulated deficit			deficit
Balance December 31, 2020		1,000,000	$	1,000		668,338,264	$	668,338	$	34,086,086		$	—	$	(51,560,884	)	$	(16,805,460	)

Common stock issued for services to consultants		—		—		5,000,000		5,000		279,500			—		—			284,500
Shares of common stock issued for conversion of debt		—		—		5,368,493		5,368		48,317			—		—			53,686
Shares of common stock issued in relation to convertible debt		—		—		5,850,000		5,850		232,375			—		—			238,225
Reclass of derivative liability upon settlement of convertible notes payable		—		—						654,170			—		—			654,170
Cashless exercise of warrants				—		1,400,000		1,400		(1,400	)		—		—			—

Net income		—		—		—		—		—			—		3,721,651			3,721,651

Balance March 31, 2021		1,000,000	$	1,000		685,956,757	$	685,957	$	35,299,048		$	—	$	(47,839,233	)	$	(11,853,228	)

Shares of common stock issued for conversion of debt		—		—		8,000,000		8,000		107,200			—		—			115,200
Shares of common stock issued in relation to convertible debt		—		—		4,000,000		4,000		180,000			—		—			184,000
Reclass of derivative liability upon settlement of convertible notes payable		—		—						284,000			—		—			284,000
Cashless exercise of warrants		—				3,906,000		3,906		(3,906	)		—		—			—
Common stock issued for services to consultants		—		—		—		—		—			180,000		—			180,000

Net income		—		—		—		—		—			—		798,957			798,957

Balance June 30, 2021		1,000,000	$	1,000		701,862,757	$	701,863	$	35,866,342		$	180,000	$	(47,040,274	)	$	(10,291,069	)

Reclass of derivative liability upon settlement of convertible notes payable		—		—		—		—		87,875			—		—			87,875

Net Loss		—		—		—		—		—			—		(2,478,256	)		(2,478,256	)

Balance September 30, 2021		1,000,000	$	1,000		701,862,757	$	701,864	$	35,954,217		$	180,000	$	(49,518,533	)	$	(12,681,452	)

Balance December 31, 2019		1,000,000	$	1,000		643,121,923	$	643,122	$	32,152,715			—	$	(38,954,344	)	$	(6,157,507	)
Shares of common stock issued for conversion of debt		—		—		2,000,000		2,000		6,800			—		—			8,800
Common stock shares issued for services		—		—		281,955		282		4,792			—		—			5,074
Reclass of derivative liability upon settlement of convertible notes payable		—		—		—		—		86,700			—		—			86,700

Net loss		—		—		—		—		—			—		(2,296,759	)		(2,296,759	)

Balance March 31, 2020		1,000,000	$	1,000		645,403,878		645,404	$	32,251,007			—		(41,251,103	)	$	(8,353,692	)

Shares of common stock issued for conversion of debt		—		—		5,588,333		5,588		15,862			—		—			21,450
Reclass of derivative liability upon settlement of convertible notes payable		—		—		—		—		994,771			—		—			994,771
Shares issued for exercise of warrants		—		—		6,000,000		6,000		54,000			—		—			60,000
Convertible note forbearance agreement		—		—		796,056		796		14,329			—		—			15,125

Net loss		—		—		—		—		—			—		(3,789,346	)		(3,789,346	)

Balance June 30, 2020		1,000,000	$	1,000		657,788,267	$	657,788	$	33,329,969			—	$	(45,040,449	)	$	(11,051,692	)

Common stock shares issued for expenses		—		—		3,300,000		3,300		6,930			—		—			10,230
Shares issued for conversion of Accounts Payable		—		—		6,500,000		6,500		81,500			—		—			88,000
Reduction in derivative liability		—		—		—		—		—			—		—			—
Common stock issued for services to consultants		—		—		—		—		—			—		—			—

Net income		—		—		—		—		—			—		2,682,849			2,682,849

Balance September 30, 2020		1,000,000	$	1,000		667,588,264	$	667,588	$	33,418,400		$	—	$	(42,357,600	)	$	(8,270,612	)


	Common Stock				Preferred Stock				Paid-In			Shares		Accumulated
	Shares		Amount		Shares		Amount		Capital			Issuable		Deficit			Total
Balance, December 31, 2020		668,338,264	$	668,338		1,000,000	$	1,000	$	34,086,086			—	$	(51,560,884	)	$	(16,805,460	)

Shares Issued for conversion of debt		50,619,573		50,620		—		—		1,027,933			—		—			1,078,553

Shares issued for issuance of debt		8,000,000		8,000		—		—		384,000			—		—			392,000

Shares issued for services		5,000000		5,000		—		—		279,500			180,000		—			464,500

Reduction in derivative liability		—		—		—		—		1,602,171			—		—			1,602,171

Warrant Exercise		5,306,021		5,306		—		—		(9,306	)		—		—			(4,000	)

Net Income		—		—		—		—		—			—		2,211,309			2,211,309

Balance, December 31, 2021		737,263,858	$	737,264		1,000,000	$	1,000	$	37,370,384		$	180,000	$	(49,349,575	)	$	(11,060,927	)

Shares Issued for conversion of debt		34,749,109		34,749		—		—		386,433			—		—			421,182

Shares issued for issuance of debt		—		—		—		—		—			—		—			—

Shares issued for services		—		—		—		—		—			—		—			—

Reduction in derivative liability		—		—		—		—		—			—		—			—

Warrant exercise		—		—		—		—		—			—		—			—

Option exercise		—		—		—		—		—			—		—			—

Net Loss		—		—		—		—		—			—		(930,083	)		(930,083	)

Balance, March 31, 2022		772,012,967	$	772,013		1,000,000	$	1,000	$	37,756,817		$	180,000	$	(50,279,658	)	$	(11,569,828	)


	For the Nine Months Ended
	September 30, 2021			September 30, 2020
Operating Activities
Net income/( loss)	$	2,042,352		$	(3,403,256	)
Adjustments to reconcile net loss to net cash used in operating activities:
Shares issued for services		464,500
Stock-based compensation		—			30,430
Change in fair value of derivative liability		(6,439,186	)		(236,206	)
Change in fair value of warrant liability		(894,000	)
Amortization of debt discount		1,681,178			654,584
Consulting fees added to note payable principal		180,000
Interest expense from derivative liability		42,400			1,709,894
Interest expense from warrant liability		891,000
Interest expense for extension fees added to principal		225,000
Operating expenses setled through debt proceeds		—			27,300
Legal fees for note issuance		33,751
Depreciation		2,539

Changes in operating assets and liabilities:
Prepaid expenses		(135,000	)		(514,000	)
Accounts payable		(118,366	)		(11,141	)
Accrued expenses		133,447			210,550
Net cash used in operating activities		(1,890,386	)		(1,531,845	)

Investing Activities
Purchase of Equipment		—			(24,500	)
Software Development Cost		—			(102,823	)
Due to Related Party		(66,971	)		(106,225	)
Net cash (used in) investing activities		(66,971	)		(233,548	)

Financing Activities
Proceeds from notes payable		—			803,125
Payments on notes payable		(125,000	)		—
Payments to related party		(53,000	)
Repayments of convertible notes		(494,352	)		(571,750	)
Proceeds from convertible notes		3,275,000			1,077,000
Proceeds from issuance of common stock		—			60,000
Advances from officer		(643,552	)
Net cash provided by financing activities		1,959,096			1,368,375

Net decrease in cash and cash equivalents		1,739			(397,018	)
Cash and cash equivalents at beginning of period		264			493,402

Cash and cash equivalents at end of period	$	2,003		$	96,384

Supplementary disclosure of cash flow information
Cash paid during the year for:
Interest	$	—		$	28,812
Taxes	$	—		$	—
Supplementary disclosure of non-cash investing and financing activities
Convertible notes paid by officer	$	390,261		$
Accrued expenses settled through notes payable		—			180,000
Debt discount from derivative on convertible notes payable	$	178,000		$	923,500
Debt discount for issuance of shares of common stock with convertible note	$	422,225		$
Debt discount for issuance of warrants with convertible note	$	1,507,000		$
Discount on convertible notes payable	$	490,214		$	30,250
Conversion of Convertible notes payable	$	168,886		$
Cashless exercise of warrants	$	5,306		$
Settlement of derivative liability to APIC	$	1,026,045		$
Convertible notes paid by affiliate	$	53,000		$

	March 31,			December 31,
	2022			2021
Cash flows from operating activities:
Net (Loss) Income	$	(930,083	)	$	2,211,309
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation		—			12,695
Amortization of debt discount		482,234			2,303,945
Change in fair value of derivative liability		45,000			(7,348,389	)
Change in fair value of warrant liability		(178,500	)		(1,782,000	)
Shares issued for services		—			464,500
Consulting fees added to note payable principal		137,000			240,000
Shares issued for financing fees		—
Interest expense from warrant liability		—			881,000
Extension fees added to principal balance		—			250,000
Loss on conversion of convertible notes payable		85,241			—
Legal fees for note issuance		—			17,795

Changes in operating assets and liabilities:
Prepaid expenses		22,500			(22,500	)
Prepaid expense from related party		—			315,000
Due from related entity		42,473			(10,204	)
Accounts payable		1,367			(124,780	)
Accrued expenses		219,714			203,356
Due to officer		(46,719	)		(251,291	)
Net cash (used in) operating activities		(119,773	)		(2,639,564	)

Cash flows from investing activities:		—			—

Cash flows from financing activities:
Proceeds from notes payable		—			—
Payments of notes payable		—			(125,000	)
Proceeds from convertible notes payable		100,000			3,403,750
Payments of convertible notes payable		(75,488	)		(5,40,650	)
Net cash provided by financing activities		24,512			27,38,100

Net (decrease) increase in cash		(95,261	)		98,536

Cash at beginning of year		98,800			264

Cash at end of year	$	3,539		$	98,800

Non-Cash Items
Convertible notes paid by officer		—			253,000
Debt discount from derivative on convertible notes payable		—			386,823
Reduction in derivative liability from payments on convertible notes payable		—			1,602,171
Reduction in derivative liability from conversion on convertible notes payable		—			(4,000	)
Debt discount from issuance of warrants with convertible note payable		—			1,507,000
Discount on convertible notes payable		3,750			(490,214	)
Conversion of Convertible notes payable		—			(743,583	)
Cashless exercise of warrants		—			5,306
Settlement of derivative liability to APIC		—			1,743,908
Convertible debt settled through issuance of common shares		421,182			1,078,553
Debt Discount from issuance of stock conversion of debt		—			(392,000	)
Shares issued for Convertible debt		—			392,000
Reduction in accrued compensation and due to officer		—			53,000


	Nine Months Ended				Three Months Ended
	September 30,				March 31,
	2021		2020		2022		2021
Convertible notes and accrued interest		107,858,931		274,444,313		406,572,394		96,942,662
Preferred Stock		259,689,294		214,560,000		255,284,000		255,284,000
Stock options		13,650,002		13,650,002		13,650,002		13,650,002
Warrants		46,250,000		1,500,000		56,096,875		35,250,000
Potentially dilutive securities		427,448,227		504,154,315		731,603,271		401,126,664

	September 30, 2021		December 31, 2020
Accrued compensation to executive officers and employee	$	145,834	$	142,315
Accrued professional fees and settlements		65,672		259,119
Accrued interest		1,009,673		942,446
Total	$	1,221,179	$	1,343,880

	March 31, 2022		December 31, 2021
Accrued compensation to executive officers	$	100,834	$	90,834
Accrued professional fees and settlements		86,388		86,392
Accrued interest		1,504,929		1,304,684
Total accrued expenses	$	1,692,151	$	1,481,910

	September 30, 2021			December 31, 2020			March 31, 2022		December 31, 2021
Derivative liability:
Balance at beginning of period	$	9,367,159		$	1,158,008		$	809,000	$	9,367,159
Additions		220,401			2,802,754			117,000		542,230
Settlements		(1,026,046	)		(1,743,734	)		—		(1,752,000	)
Change in fair value		(6,439,186	)		7,132,131			45,000		(7,348,389	)
Balance at end of period	$	2,122,328		$	9,367,159
Balance at end of year							$	971,000	$	809,000

	September 30, 2021			December 31, 2020
Warrant liability:
Balance at beginning of period	$	—		$	—
Additions		2,398,000			—
Change in fair value		(894,000	)		—
Balance at end of period	$	1,504,000		$	—

	Total			William Delgado			Jerome Gomolski
Balance December 31, 2020	$	142,315		$	64,481		$	77,834

Salary nine months ended September 30, 2021		1,032,258			999,258			33,000

Promissory notes paid by William Delgado		390,261			390,261			—
Payments		(1,419,000	)		(1,394,000	)		(25,000	)
Balance September 30, 2021	$	145,834		$	60,000		$	85,834

				William			Jerome
	Total			Delgado			Gomolski
Balance December 31, 2021	$	90,834		$	0		$	90,834

Q1 2022 Salary		75,000			60,000			15,000

Payments		(65,000	)		(60,000	)		(5,000	)
Balance March 31, 2022	$	100,834		$	0		$	100,834

	Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2022			2021
Net cash used in operating activities	$	(1,890,386	)	$	(1,531,845	)	$	(119,773	)	$	(492,213	)
Net cash used in investing activities		(66,971	)		(233,548	)		—			—
Net cash provided by financing activities		1,959,096			1,368,375			24,512			817,500
Increase (decrease) in cash	$	1,739		$	(397,018	)	$	(95,261	)	$	325,287

~~Exhibit~~		Incorporated by Reference
Exhibit Number	Exhibit Description	Form	Exhibit	Filing Date
31.1*	Certification of Principal Executive Officer
31.2*	~~Certification~~Ceritfication of Principal Financial Officer
32.1**	Section 1350 Certification of Principal Executive Officer
32.2**	Section 1350 Certification of Principal Financial Officer
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

By:	/s/ William J. Delgado
William J. Delgado
Chief Executive Officer
Date: ~~November 22, 2021~~		May 25, 2022

By:	/s/ Jerome J. Gomolski
Jerome J. Gomolski
Chief Financial Officer
Date: ~~November 22, 2021~~		May 25, 2022